-
Population Pharmacokinetic/Pharmacodynamic Modeling of Tacrolimus in Renal Transplant Recipients: Impact of CYP3A5 Genotype and Wuzhi Capsule Co-Medication
16 Sep 2025 09:23 GMT
… ~93%.12,13 Therapeutic drug monitoring (TDM) is … renal transplant and underwent treatment with tacrolimus-based regimens. … were also collected. The co-medications (amlodipine, WZ capsule, metoprolol … non-renal toxicities (diarrhea, dyspepsia, insomnia) in renal …
-
This common over the counter drug could increase dementia 'by a third'
14 Sep 2025 12:18 GMT
… alleviates issues such as heartburn, dyspepsia, and acid regurgitation, whilst … the best treatment for them, and because stopping these drugs abruptly may … since participants were questioned about medication usage annually, their consumption between …
-
Drug Safety Alert: IPC Flags Adverse Reactions linked to Tranexamic acid and Metoclopramide
07 Sep 2025 13:32 GMT
… of gastroduodenal dysfunction, including heartburn, dyspepsia, nausea and vomiting associated with … .
Suspected Drug
Indication(s)
Adverse Drug Reactions (ADRs)
1
Tranexamic Acid
• Treatment of … use of the above suspected drugs.
Further, the safety alert …
-
Common over the counter drug taken by millions 'could increase dementia risk by a third'
01 Sep 2025 08:33 GMT
… alleviates issues such as heartburn, dyspepsia, and acid regurgitation, whilst … the best treatment for them, and because stopping these drugs abruptly may … since participants were questioned about medication usage annually, their consumption between …
-
Eli Lilly Stock Rises as Firm Plans to Ask for Weight-Loss Pill Approval
26 Aug 2025 14:17 GMT
… apply for approval of the drug from regulators
Eli Lilly … loss pill met primary and key secondary endpoints.
The GLP-1 medication … of its oral GLP-1 treatment, orforglipron, met primary and … 4%), constipation (22.4%), and dyspepsia (10.9%). In addition, a …
-
Serena Williams lost 14 kg using GLP-1 drug: 8 things to know about the weight loss medication
25 Aug 2025 00:55 GMT
… got her GLP-1 treatment through direct-to- … and reducing weight. Certain medications also combine GLP-1 … Food and Drug Administration, these weight loss drugs can have … appetite, vomiting, constipation, indigestion (dyspepsia), and stomach (abdominal) pain. …
-
NeurAxis Stock Surges On FDA Clearance For IB-Stim In Pediatric Functional Dyspepsia Treatment
20 May 2025 17:59 GMT
… and Drug Administration for IB-Stim for the treatment of Pediatric Functional Dyspepsia … treatment ever cleared or approved by the FDA related to functional dyspepsia … . Expanding into the treatment of Pediatric Functional Dyspepsia pain that includes related …
-
At McMurray Auction — Powders, Pills & Tonics Took Top Billing
16 Jul 2025 18:54 GMT
… pills — a sugar-coated pill used for “constipation, headaches, indigestion, dyspepsia … bottle for The Keeley Treatment for Inebriety, which was … glass bottle of Jaffray Drug Company’s “medicine for … Warner’s Renowned Simple Goiter Remedy, a “later Warner …
-
Erosive Esophagitis Market Epidemiology Report 2025-2035: Pipeline Therapies, Drugs Sales, and Regional Outlook
11 Jul 2025 12:23 GMT
… allow clinicians to create individualized treatment plans. These technologies enable … , including obesity and functional dyspepsia, is also impacting the … esophagitis marketed drugs and late-stage pipeline drugs.
In-Market Drugs
Drug Overview
…
-
Functional Dyspepsia Market Analysis And Forecast, 2025-2035, Competitive Analysis Of Astrazeneca, P&G, Takeda, Prestige Consumer Healthcare, Kenvue Brands, Dr. Reddy's, Pfizer, ZERIA, Daewoong
11 Jul 2025 09:39 GMT
… is seeing innovation through pharmacological treatments, lifestyle changes, and alternative … in functional dyspepsia, helping companies identify opportunities for drug and technology … insights to design therapies, medications, and platforms tailored to …